Christus Health appoints Lillian Montoya to New Mexico region senior vice president
A news release announcing the newly created role did not provide details about the position's responsibilities but said the move reflects Christus' commitment to delivering "exceptional, locally led care across the state."
"Lillian Montoya is a purpose-driven leader who has delivered outstanding results and inspired transformation in every role she's held," said Ernie Sadau, Christus Health president and CEO, in a statement. "Her expanded role positions us to unify and further the care we provide throughout New Mexico."
Christus Health has locations across the states; its largest facility in New Mexico, Christus St. Vincent Regional Medical Center, is in Santa Fe. The health system in 2023 acquired Gerald Champion Regional Medical Center, and last month said it purchased land in Los Alamos where it plans to build a multi-specialty facility.
Montoya, born in New Mexico, has been with Christus for 11 years. She has been in leadership roles since 2013 and became president and CEO in 2018.
The news release touted Montoya's leadership, saying that under her tutelage, Christus St. Vincent received a four-star rating from the Centers for Medicare and Medicaid Services.
"I am deeply honored to step into this regional leadership role," Montoya said in the statement. "I look forward to continuing our work in caring for the many — alongside our incredible caregivers and partners — ensuring that our communities receive the very best care, grounded in compassion and excellence."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Possible metal found in ground beef: Michigan company issues recall across 5 states
A Michigan-based meat company recalled more than 1,000 pounds of fully cooked ground beef after a customer reported finding pieces of metal in the product, it said in a release. Ada Valley Meat Company on Tuesday said recalled products were shipped to businesses and distributors across five states: California, Delaware, Illinois, Michigan and Pennsylvania. The affected items came in 20-pound boxes containing four 5-pound bags of "Ada Valley Fully Cooked Ground Beef" from specific lots -- pack date May 28 with lot code 35156 and pack date May 30 with lot code 35157 -- the company said. The products subject to recall also bear establishment number "EST. 10031" inside the U.S. Department of Agriculture (USDA) mark of inspection, it said. While no injuries have been reported, food safety officials are concerned that some of the recalled products might still be in institutional freezers, Ada Valley noted. "We are taking this step out of an abundance of caution and in line with our core value: the safety and trust of our customers come first," Gerrit Rozeboom, the company's president, said in a statement sent to ABC News. MORE: High Noon voluntarily recalls some vodka seltzer drinks that were mislabeled as Celsius energy drinks The USDA Food Safety and Inspection Service advised institutions not to serve these products and instead throw them away or return them to where they were purchased. "We are working closely with regulators to investigate the issue and have already implemented additional safety measures and quality checks to prevent future occurrences," Rozeboom told ABC News. Customers with questions about the recall can contact the USDA Meat and Poultry Hotline at 888-674-6854 or email MPHotline@
9 hours ago
Possible metal found in ground beef: Michigan company issues major recall across 5 states
A Michigan-based meat company recalled more than 1,000 pounds of fully cooked ground beef after a customer reported finding pieces of metal in the product, it said in a release. Ada Valley Meat Company on Tuesday said recalled products were shipped to businesses and distributors across five states: California, Delaware, Illinois, Michigan and Pennsylvania. The affected items came in 20-pound boxes containing four 5-pound bags of "Ada Valley Fully Cooked Ground Beef" from specific lots -- pack date May 28 with lot code 35156 and pack date May 30 with lot code 35157 -- the company said. The products subject to recall also bear establishment number "EST. 10031" inside the U.S. Department of Agriculture (USDA) mark of inspection, it said. While no injuries have been reported, food safety officials are concerned that some of the recalled products might still be in institutional freezers, Ada Valley noted. "We are taking this step out of an abundance of caution and in line with our core value: the safety and trust of our customers come first," Gerrit Rozeboom, the company's president, said in a statement sent to ABC News. The USDA Food Safety and Inspection Service advised institutions not to serve these products and instead throw them away or return them to where they were purchased. "We are working closely with regulators to investigate the issue and have already implemented additional safety measures and quality checks to prevent future occurrences," Rozeboom told ABC News. Customers with questions about the recall can contact the USDA Meat and Poultry Hotline at 888-674-6854 or email MPHotline@
Yahoo
11 hours ago
- Yahoo
AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO
AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market. CEO Pascal Soriot told reporters Tuesday that the company, which reported its best quarter to date on the same day, "We are a very American company. We are global, but we are certainly very much rooted and present in the US." Tuesday's comment comes as the UK-based and UK-listed company is reportedly considering moving its main stock market listing to New York. In addition, the company recently announced $50 billion in manufacturing commitments in the US — including a brand-new facility in Virginia — and stated its goal of having 50% of its revenue come from the US by 2030. AstraZeneca's top-selling drugs include cancer drug Tagrisso and diabetes drug Farxiga. CFO Aradhana Sarin told Yahoo Finance that the moves are independent of Trump's tariff threats of up to 200% on the pharmaceutical industry. "We have been thinking about our strategic manufacturing — this probably goes back 3 or 4 years," she said. "So, post-COVID, we made a strategic decision because we're such a global company that we needed to have segregated supply chains." "This new facility [in Virginia] that we announced was part of the plan anyway," she added. "But that's separate, it's nothing to do with tariffs. It's actually based on the demand that we see potentially for our new cardiovascular medicine." And there are other reasons why the market is more appealing — including how quickly products reach patients in the US versus other countries. "When new therapies come ... the US market is almost the first to provide access to patients. Physicians ... are really into looking at the data," Sarin said, explaining why the US market is more appealing to pharma than other markets. AstraZeneca is also focused on other strategies that appeal to the US government, including price cuts. It sent a proposal to the US government on price reductions for some of its drugs. The proposal is under review, Soriot said. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Click here for in-depth analysis of the latest health industry news and events impacting stock prices Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
